CARCINOMA

This study tested whether adding the drug aflibercept to standard chemotherapy (docetaxel) could help people with advanced non-small cell lung cancer live longer. The trial included 913 patients whose cancer had worsened after initial platinum-based treatment. The main goal was t…

This early-phase study tested a new treatment for people with advanced non-small cell lung cancer that had grown or returned after standard therapy. Researchers took participants' own immune cells, modified them in a lab to better recognize and attack cancer, and infused them bac…

This study tested a short-term talk therapy (psychodynamic psychotherapy) for 24 adults with advanced solid tumors and high emotional distress. The goal was to see if the therapy is safe, acceptable, and feasible. Researchers measured side effects, drop-out rates, and how well th…

This study tested a financial navigation program to help cancer patients in rural and non-rural North Carolina deal with the high costs of care. 258 adults with cancer and significant financial distress took part. The program aimed to reduce financial toxicity and improve quality…

This study looked at whether a new biomarker called 'mass response' can help predict how well cancer treatments will work. Researchers collected tumor cells from 72 adults with various cancers using fluid samples or biopsies. The goal was to see if this biomarker could guide ther…

This study looked at whether certain chemicals called organochlorines, which are stored in body fat, are more common in people with pancreatic cancer. Researchers compared 56 patients with and without the disease. The goal was to see if these chemicals might be a risk factor for …